As of Jun 16, 2025, the Mannkind stock's PE ratio is 38.1. This takes into account the latest EPS of $0.1 and stock price of $3.81. The PE ratio marks a decrease of 49% from its last 4 quarters average of 74.4.
The PE ratio of Mannkind has averaged 51.91 over the last nine years. The current P/E ratio of 38.1 is 27% lower than the historical average. Looking back at the last nine years, MNKD's PE ratio peaked in the Mar 2024 quarter at 113.25, when the price was $4.53 and the EPS was $0.04. The lowest point was in the Jun 2017 quarter, when it reached 1.02 with a price of $1.41 and an EPS of $1.38.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 64.3 | N/A | $6.43 | $0.1 |
2023 | N/A | N/A | $3.64 | -$0.04 |
2022 | N/A | N/A | $5.27 | -$0.34 |
2021 | N/A | N/A | $4.37 | -$0.32 |
2020 | N/A | N/A | $3.13 | -$0.26 |
2019 | N/A | N/A | $1.29 | -$0.27 |
2018 | N/A | N/A | $1.06 | -$0.6 |
2017 | N/A | N/A | $2.32 | -$1.13 |
2016 | 2.32 | N/A | $3.18 | $1.37 |
2015 | N/A | N/A | $7.25 | -$4.54 |
2014 | N/A | N/A | $26.08 | -$2.57 |
2013 | N/A | N/A | $26 | -$3.2 |
2012 | N/A | N/A | $11.55 | -$4.7 |
2011 | N/A | N/A | $12.5 | -$6.6 |
2010 | N/A | N/A | $40.3 | -$7.5 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 50.3 | -21.77% | $5.03 | $0.1 |
Dec 2024 | 64.3 | -18.22% | $6.43 | $0.1 |
Sep 2024 | 78.63 | -24.68% | $6.29 | $0.08 |
Jun 2024 | 104.4 | -7.81% | $5.22 | $0.05 |
Mar 2024 | 113.25 | N/A | $4.53 | $0.04 |
Dec 2023 | N/A | N/A | $3.64 | -$0.04 |
Sep 2023 | N/A | N/A | $4.13 | -$0.12 |
Jun 2023 | N/A | N/A | $4.07 | -$0.19 |
Mar 2023 | N/A | N/A | $4.1 | -$0.28 |
Dec 2022 | N/A | N/A | $5.27 | -$0.34 |
Sep 2022 | N/A | N/A | $3.09 | -$0.38 |
Jun 2022 | N/A | N/A | $3.81 | -$0.34 |
Mar 2022 | N/A | N/A | $3.68 | -$0.37 |
Dec 2021 | N/A | N/A | $4.37 | -$0.32 |
Sep 2021 | N/A | N/A | $4.35 | -$0.33 |
You can ether set your own Fair P/E multiple or use one of the automatically calculated Fair P/E multiples.
PE Ratio is an attempt to estimate a fair PE ratio of a stock based on its earnings and growth rate.
This formula is a modified version of the classic Graham-Dodd Formula (V= EPS x (8.5+2g)), originally developed by Benjamin Graham, to calculate the fair price of a stock based on its earnings and growth rate.
The formula we have created is an adaptation of this approach, designed to maintain a balance between simplicity and growth sensitivity.
It is calculated using the following formula:
IF g < 5: Fair PE = b
IF g >= 5: Fair PE = m × g
Here’s what each part of the formula means:
g: Growth is calculated as the average of the three-year average EPS growth rate and the one-year EPS growth rate (annually). This approach provides a balanced measure of growth by factoring in both the long-term growth trend and the most recent annual growth performance. If one of the growth metrics is not available, the remaining metric is used to determine growth. The fair P/E value is capped at 100 to prevent distortions caused by extreme EPS growth rates, such as those resulting from large percentage increases from a low base.
m: This is the long term historical median PEG (Price/Earnings to Growth) ratio of the overall market. It serves as a benchmark, adjusting the Fair PE based on typical market conditions.
b: Base PE (static value set to 8). If the company's growth rate is less than 5, the Fair PE is set at a conservative baseline of 8. This is because declining companies generally deserve a lower PE ratio.
Fixed: The Fair PE ratio for all data points is calculated using a single, constant average EPS growth rate, determined based on the most recent period. This means that the same growth rate is applied to all historical data points. Dynamic: The Fair PE ratio for each historical data point is calculated using the trailing average EPS growth rate specific to that point in time. This means that for each data point, the corresponding trailing EPS growth rate is used, ensuring that the Fair PE ratio reflects the growth conditions that were relevant at that specific point in history.
MNKD's current PE ratio is lower than its 3, 5 and 10-year averages.
MNKD's PE ratio stands lower than its peer stock LLY, but it is higher than MRK's and PFE's. Mannkind's current PE ratio of 38.1 is higher than the average of its peers, which is 27.19.
Stock name | PE ratio | Market cap |
---|---|---|
MRK Merck & Co Inc | 11.43 | $197.74B |
HALO Halozyme Therapeutics Inc | 13.77 | $6.53B |
PFE Pfizer Inc | 17.32 | $136.88B |
MNKD Mannkind Corp | 37.6 | $1.14B |
LLY ELI LILLY & Co | 64.28 | $751.71B |
NKTR Nektar Therapeutics | N/A | $110.79M |
The price to earnings ratio for MNKD stock is 38.1 as of Jun 16, 2025.
The average PE ratio for MNKD stock over the past 3 years is 82.18.
The average PE ratio for MNKD stock over the past 5 years is 82.18.
The highest quarterly PE ratio in the last nine years has been 113.25 and it was in the Mar 2024 quarter.
MNKD's price to earnings ratio is currently 27% below its 9-year historical average.
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jun 16, 2025), Mannkind's share price is $3.81. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.1. Therefore, Mannkind's PE ratio for today is 38.1. PE RATIO(38.1) = STOCK PRICE($3.81) / TTM EPS($0.1)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.